EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets

Alvina I Khamidullina iD, Yaroslav E Abramenko iD, Alexandra V Bruter, Victor V Tatarskiy iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25021263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Alvina I Khamidullina und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncobiology, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov Street, 119334 Moscow, Russia. Hauptthemen laut MEDLINE: DNA Damage, Neoplasms. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Replication stress (RS) is a characteristic state of cancer cells as they tend to exchange precision of replication for fast proliferation and increased genomic instability. To overcome the consequences of improper replication control, malignant cells frequently inactivate parts of their DNA damage response (DDR) pathways (the ATM-CHK2-p53 pathway), while relying on other pathways which help to maintain replication fork stability (ATR-CHK1). This creates a dependency on the remaining DDR pathways, vulnerability to further destabilization of replication and synthetic lethality of DDR inhibitors with common oncogenic alterations such as mutations of TP53, RB1, ATM, amplifications of MYC, CCNE1 and others. The response to RS is normally limited by coordination of cell cycle, transcription and replication. Inhibition of WEE1 and PKMYT1 kinases, which prevent unscheduled mitosis entry, leads to fragility of under-replicated sites. Recent evidence also shows that inhibition of Cyclin-dependent kinases (CDKs), such as CDK4/6, CDK2, CDK8/19 and CDK12/13 can contribute to RS through disruption of DNA repair and replication control. Here, we review the main causes of RS in cancers as well as main therapeutic targets—ATR, CHK1, PARP and their inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA DamageNeoplasmsAtaxia Telangiectasia Mutated ProteinsCheckpoint Kinase 1Cell Cycle CheckpointsCell Cycle ProteinsDNA Replication

Stichwörter der Autor:innen

ATRCHK1DNA damage responsePARPPKMYT1WEE1cyclin dependent kinasesreplication stress

Substanzen

Ataxia Telangiectasia Mutated ProteinsCheckpoint Kinase 1Cell Cycle Proteins

Autor:innen und Institutionen

  • Laboratory of Molecular Oncobiology, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov Street, 119334 Moscow, Russia.
  • Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilov Street, 119334 Moscow, Russia.

ORCID-Profile: Alvina I Khamidullina, Yaroslav E Abramenko, Victor V Tatarskiy

Förderung

  • Russian Science Foundation

Zitieren

APA

Khamidullina, A. I., Abramenko, Y. E., Bruter, A. V., & Tatarskiy, V. V. (2024). Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25021263

Vancouver

Khamidullina AI, Abramenko YE, Bruter AV, Tatarskiy VV. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021263

BibTeX
@article{Khamidullina2024,
  author = {Khamidullina, Alvina I and Abramenko, Yaroslav E and Bruter, Alexandra V and Tatarskiy, Victor V},
  title = {Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25021263}
}
Kostenlos starten →